Clinical Trial Update: A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess and Compare to the Efficacy and Safety of Lafutidine, Famotidine and Omeprazole-referenced in Korean Erosive Esophagitis Patients [Phase 3]

View source ↗

Summary

A Phase III randomized, double-blind trial comparing Lafutidine, Famotidine, and Omeprazole in Korean patients with erosive esophagitis. The study has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis

Drugs mentioned

• Famotidine (famotidine)
• Lafutidine (lafutidine)
• Omeprazole (Omeprazole)

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Erosive Esophagitis | Phase 3 | Status: COMPLETED | Results posted: 2020-09-16